Ingalls & Snyder LLC Chembio Diagnostics, Inc. Transaction History

Ingalls & Snyder LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 31, 2020	SELL	$3.18 - $15.54 $847,384 - $4.14 Million	-266,473 Closed	0 $0
Q1 2020 Apr 22, 2020	SELL	$2.36 - $5.6 $100,939 - $239,517	-42,771 Reduced 13.83%	266,473 $1.36 Million
Q4 2019 Jan 15, 2020	BUY	$3.94 - $5.76 $23,640 - $34,560	6,000 Added 1.98%	309,244 $1.41 Million
Q3 2019 Oct 16, 2019	BUY	$4.84 - $7.25 $25,008 - $37,460	5,167 Added 1.73%	303,244 $1.86 Million
Q2 2019 Jul 11, 2019	SELL	$5.56 - $7.85 $8,340 - $11,775	-1,500 Reduced 0.5%	298,077 $1.82 Million
Q1 2019 Apr 11, 2019	SELL	$5.32 - $7.18 $96,089 - $129,685	-18,062 Reduced 5.69%	299,577 $1.66 Million
Q4 2018 Jan 24, 2019	BUY	$4.95 - $10.5 $65,691 - $139,345	13,271 Added 4.36%	317,639 $1.8 Million
Q3 2018 Oct 24, 2018	BUY	$9.2 - $11.5 $2.8 Million - $3.5 Million	304,368 New	304,368 $3.2 Million

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.